231 related articles for article (PubMed ID: 33183118)
1. Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis.
Tee HK; Zainol MI; Sam IC; Chan YF
Expert Rev Anti Infect Ther; 2021 Jun; 19(6):733-747. PubMed ID: 33183118
[No Abstract] [Full Text] [Related]
2. Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses.
Ong KC; Wong KT
Brain Pathol; 2015 Sep; 25(5):614-24. PubMed ID: 26276025
[TBL] [Abstract][Full Text] [Related]
3. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies.
Fang CY; Liu CC
Expert Opin Drug Discov; 2022 Jan; 17(1):27-39. PubMed ID: 34382876
[TBL] [Abstract][Full Text] [Related]
4. Cellular receptors for enterovirus A71.
Kobayashi K; Koike S
J Biomed Sci; 2020 Jan; 27(1):23. PubMed ID: 31924205
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Asia-Pacific Network for Enterovirus Surveillance.
Chiu ML; Luo ST; Chen YY; Chung WY; Duong V; Dussart P; Chan YF; Perera D; Ooi MH; Thao NTT; Truong HK; Lee MS
Vaccine; 2020 Jan; 38(1):1-9. PubMed ID: 31679864
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus A71 Induces Neurological Diseases and Dynamic Variants in Oral Infection of Human SCARB2-Transgenic Weaned Mice.
Lin JY; Weng KF; Chang CK; Gong YN; Huang GJ; Lee HL; Chen YC; Huang CC; Lu JY; Huang PN; Chiang HJ; Chen CM; Shih SR
J Virol; 2021 Oct; 95(21):e0089721. PubMed ID: 34379497
[TBL] [Abstract][Full Text] [Related]
8. Recent progress and challenges in drug development to fight hand, foot and mouth disease.
Lim ZQ; Ng QY; Ng JWQ; Mahendran V; Alonso S
Expert Opin Drug Discov; 2020 Mar; 15(3):359-371. PubMed ID: 31470744
[No Abstract] [Full Text] [Related]
9. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
10. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
11. Sodium Copper Chlorophyllin Is Highly Effective against Enterovirus (EV) A71 Infection by Blocking Its Entry into the Host Cell.
Liu Z; Xia S; Wang X; Lan Q; Li P; Xu W; Wang Q; Lu L; Jiang S
ACS Infect Dis; 2020 May; 6(5):882-890. PubMed ID: 32233455
[TBL] [Abstract][Full Text] [Related]
12. Tribbles pseudokinase 3 promotes enterovirus A71 infection via dual mechanisms.
Wang H; Li K; Cui B; Yan H; Wu S; Wang K; Yang G; Jiang J; Li Y
Emerg Microbes Infect; 2024 Dec; 13(1):2307514. PubMed ID: 38240287
[TBL] [Abstract][Full Text] [Related]
13. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
14. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
15. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
[No Abstract] [Full Text] [Related]
16. An auto-antibody identified from phenotypic directed screening platform shows host immunity against EV-A71 infection.
Cheng YW; Chuang YC; Huang SW; Liu CC; Wang JR
J Biomed Sci; 2022 Feb; 29(1):10. PubMed ID: 35130884
[TBL] [Abstract][Full Text] [Related]
17. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems.
Bian L; Gao F; Mao Q; Sun S; Wu X; Liu S; Yang X; Liang Z
Expert Rev Anti Infect Ther; 2019 Apr; 17(4):233-242. PubMed ID: 30793637
[TBL] [Abstract][Full Text] [Related]
18. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
Fang CY; Liu CC
Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
[TBL] [Abstract][Full Text] [Related]
20. Antivirals and vaccines for Enterovirus A71.
Lin JY; Kung YA; Shih SR
J Biomed Sci; 2019 Sep; 26(1):65. PubMed ID: 31481071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
